PMID: 11335699May 4, 2001Paper

Central nervous system disease in patients with macrophagic myofasciitis

Brain : a Journal of Neurology
F J AuthierRomain K Gherardi

Abstract

Macrophagic myofasciitis (MMF), a condition newly recognized in France, is manifested by diffuse myalgias and characterized by highly specific myopathological alterations which have recently been shown to represent an unusually persistent local reaction to intramuscular injections of aluminium-containing vaccines. Among 92 MMF patients recognized so far, eight of them, which included the seven patients reported here, had a symptomatic demyelinating CNS disorder. CNS manifestations included hemisensory or sensorimotor symptoms (four out of seven), bilateral pyramidal signs (six out of seven), cerebellar signs (four out of seven), visual loss (two out of seven), cognitive and behavioural disorders (one out of seven) and bladder dysfunction (one out of seven). Brain T(2)-weighted MRI showed single (two out of seven) or multiple (four out of seven) supratentorial white matter hyperintense signals and corpus callosum atrophy (one out of seven). Evoked potentials were abnormal in four out of six patients and CSF in four out of seven. According to Poser's criteria for multiple sclerosis, the diagnosis was clinically definite (five out of seven) or clinically probable multiple sclerosis (two out of seven). Six out of seven patients had...Continue Reading

Citations

Oct 2, 2002·Arthritis and Rheumatism·Sandrine GuisJean Roudier
Jan 9, 2008·Clinical Rheumatology·Brett J TheelerJohn P Ney
Jan 7, 2010·Cell Biology and Toxicology·Ana I CalejoPaula P Gonçalves
Oct 1, 2010·Clinical Reviews in Allergy & Immunology·Eitan IsraeliYehuda Shoenfeld
May 5, 2004·Best Practice & Research. Clinical Rheumatology·Sandrine GuisFrédéric Lioté
Mar 17, 2004·Neuromuscular Disorders : NMD·Yoram NevoDov Soffer
Sep 3, 2003·Joint, Bone, Spine : Revue Du Rhumatisme·Thomas Papo
Jan 22, 2003·Immunology and Cell Biology·Jorge E OsorioDexiang Chen
Dec 22, 2007·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Daniel KrewskiVirginie Rondeau
May 31, 2011·Journal of Toxicology and Environmental Health. Part a·Gayle Delong
Sep 1, 2002·Journal of Clinical Neuromuscular Disease·David A Simpson
Jan 12, 2012·Lupus·R K Gherardi, F J Authier
Apr 6, 2013·BMC Medicine·Zakir KhanJosette Cadusseau
Oct 2, 2013·Surgical Neurology International·Russell L Blaylock
Sep 5, 2013·Autoimmunity Reviews·Joerg-Patrick Stübgen
Aug 8, 2013·Journal of Inorganic Biochemistry·Nilusha Ragunathan-ThangarajahFrançois-Jérôme Authier
Mar 19, 2014·Cell Biochemistry and Biophysics·Weijiang WuGuozhen Hui
Jun 5, 2002·Current Opinion in Neurology·Sucheep Piyasirisilp, Thiravat Hemachudha
Apr 6, 2013·Expert Review of Clinical Immunology·Olga Vera-LastraYehuda Shoenfeld
May 21, 2005·Scandinavian Journal of Rheumatology·J H ParkD H Yoo
Aug 9, 2003·Expert Opinion on Drug Safety·Philippe Duclos
Sep 20, 2015·Journal of Inorganic Biochemistry·Guillemette CrépeauxJosette Cadusseau
Nov 22, 2011·Journal of Inorganic Biochemistry·Lucija Tomljenovic, Christopher A Shaw
Mar 12, 2011·Toxicology Letters·Alexander Batista-DuharteErnesto Oviedo-Orta
Oct 6, 2010·Journal of the Neurological Sciences·Joerg-Patrick Stübgen
Aug 17, 2010·Journal of Autoimmunity·Yehuda Shoenfeld, Nancy Agmon-Levin
Sep 15, 2009·Journal of Inorganic Biochemistry·Maryline CouetteFrançois-Jérôme Authier
Nov 23, 2007·Revue neurologique·S Guis, J F Pellissier
Feb 26, 2015·Neuropathology and Applied Neurobiology·Corinna PreusseWerner Stenzel
Aug 1, 2012·Neuropathology and Applied Neurobiology·A ShivaneA Endean
Oct 9, 2015·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Nikolai Petrovsky
Mar 22, 2005·La Revue de médecine interne·T Papo
Sep 29, 2006·Neuromuscular Disorders : NMD·Aisling M RyanCatherine Keohane
Oct 26, 2005·Pediatric Neurology·Eloy RivasAna Cabello
Feb 3, 2004·Immunology and Allergy Clinics of North America·Romain K Gherardi, François-Jérôme Authier
Jan 28, 2003·Muscle & Nerve·Joern P Sieb, Thomas Gillessen
Mar 8, 2016·Morphologie : Bulletin De L'Association Des Anatomistes·R K GherardiF J Authier
Dec 23, 2011·Annals of Medicine·Lucija Tomljenovic, Christopher A Shaw
Jun 4, 2014·Vaccine·Matthias F Kramer, Matthew D Heath
Feb 24, 2015·Frontiers in Neurology·Romain Kroum GherardiJosette Cadusseau
Dec 17, 2014·Frontiers in Neurology·Muriel RigoletFrançois Jérôme Authier
Oct 18, 2014·Internal and Emergency Medicine·Gaspare Elios RussoSilvia Lai

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.